Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -6,350 | -3,273 | -169 | -163 |
| Depreciation Amortization | 21 | -22 | 3 | 1 |
| Other Working Capital | 113 | 184 | 34 | 9 |
| Other Operating Activity | 2,084 | 231 | 14 | 31 |
| Operating Cash Flow | $-4,132 | $-2,881 | $-118 | $-122 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | N/A | 1,385 | N/A | -2 |
| PPE Investments | -94 | -121 | -8 | -9 |
| Purchase Of Investment | N/A | N/A | -65 | -12 |
| Sale Of Investment | N/A | N/A | 20 | N/A |
| Investing Cash Flow | $-94 | $1,263 | $-54 | $-22 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 5,150 | N/A | N/A | N/A |
| Common Stock Issued | 8,360 | 2 | N/A | 393 |
| Other Financing Activity | -183 | 0 | -46 | -15 |
| Financing Cash Flow | $13,326 | $2 | $-46 | $378 |
| Beginning Cash Position | 1,016 | 2,016 | 234 | 1 |
| End Cash Position | 10,117 | 401 | 17 | 234 |
| Net Cash Flow | $9,101 | $-1,616 | $-217 | $234 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,132 | -2,881 | -118 | -122 |
| Capital Expenditure | -94 | -121 | -8 | -9 |
| Free Cash Flow | -4,226 | -3,002 | -125 | -131 |